Jeil-Kirin Pharm said it held a launching symposium for Aranesp (darbepoetin alpha), a novel drug for the treatment of anemia associated with chronic renal failure, at Hotel Shilla on June 26.
At that symposium where a number of multinational investigators and local kidney specialists, Dr. Macdougall, King's College Hospital of UK, was invited as a lecturer.
Aranesp was approved by the US...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.